Differences in gonadal tissue cryopreservation practices for differences of sex development across regions in the United States
Frontiers in Endocrinology · 2023
DOI: 10.3389/fendo.2022.990359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2023. Verfasst von Aisha L Siebert und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States. Hauptthemen laut MEDLINE: Androgen-Insensitivity Syndrome, Fertility Preservation, Turner Syndrome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Some individuals with differences of sex development (DSD) conditions undergo medically indicated prophylactic gonadectomy. Gonads of individuals with DSD can contain germ cells and precursors and patients interested in future fertility preservation and hormonal restoration can participate in DSD-specific research protocols to cryopreserve this tissue. However, it is unclear how many providers or institutions offer gonadal tissue cryopreservation (GTC) and how widespread GTC for DSD is across the United States (US). The Pediatric Initiative Network (PIN) and Non-Oncologic Conditions committees of the Oncofertility Consortium sought to assess the current state of GTC for patients with DSD.
Methods
An electronic survey was sent to providers caring for patients with DSD via special interest groups of professional societies and research networks.
Results
The survey was administered between November 15, 2021 and March 14, 2022. A total of 155 providers responded to the survey, of which 132 respondents care for patients with DSD, and 78 work at facilities that offer medically indicated gonadectomy to patients with DSD diagnoses. They represented 55 US institutions including 47 pediatric hospitals, and 5 international sites (Canada, Denmark, Germany, Qatar). Of individual providers, 41% offer cryopreservation after prophylactic gonadectomy for patients with DSD (32/78). At an institutional level, GTC after medically indicated gonadectomy is available at 54.4% (24/46) of institutions. GTC is offered for a variety of DSD diagnoses, most commonly 45,X/46,XY DSD (i.e., Turner Syndrome with Y-chromosome material and mixed gonadal dysgenesis), ovotesticular DSD, complete androgen insensitivity syndrome (CAIS), and complete gonadal dysgenesis. Responses demonstrate regional trends in GTC practices with 83.3% of institutions in the Midwest, 66.7% in the Northeast, 54.6% in the West, and 35.3% in the South providing GTC. All represented institutions (100%) send gonadal tissue for pathological evaluation, and 22.7% preserve tissue for research purposes.
Conclusions
GTC after gonadectomy is offered at half of the US institutions represented in our survey, though a minority are currently preserving tissue for research purposes. GTC is offered for several DSD conditions. Future research will focus on examining presence and quality of germ cells to support clinical decision making related to fertility preservation for patients with DSD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.
- Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.
- Pediatric and Adolescent Gynecology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, United States.
- Division of Urology, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, United States.
- Department of Pediatrics, Pediatric Endocrinology, The Ohio State University College of Medicine, Columbus, OH, United States.
- Department of Obstetrics, Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Zitieren
APA
Siebert, A. L., Gomez-Lobo, V., Johnson, E. K., Nahata, L., Orwig, K. E., Pyle, L. C., Witchel, S. F., Finlayson, C., & Laronda, M. M. (2023). Differences in gonadal tissue cryopreservation practices for differences of sex development across regions in the United States. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2022.990359
Vancouver
Siebert AL, Gomez-Lobo V, Johnson EK, Nahata L, Orwig KE, Pyle LC, et al. Differences in gonadal tissue cryopreservation practices for differences of sex development across regions in the United States. Frontiers in Endocrinology. 2023. doi:10.3389/fendo.2022.990359
BibTeX
@article{Siebert2023,
author = {Siebert, Aisha L and Gomez-Lobo, Veronica and Johnson, Emilie K and Nahata, Leena and Orwig, Kyle E and Pyle, Louise C and Witchel, Selma F and Finlayson, Courtney and Laronda, Monica M},
title = {Differences in gonadal tissue cryopreservation practices for differences of sex development across regions in the United States},
journal = {Frontiers in Endocrinology},
year = {2023},
doi = {10.3389/fendo.2022.990359}
}
EUVIMED